Overview

BACE Trial Substudy 1 - PROactive Substudy

Status:
Completed

Trial end date:
2020-04-01

Target enrollment:

Participant gender:

Summary

A first sub-analysis of the BACE trial will address physical activity levels in a subgroup of the intervention study with portable validated activity monitors.

Phase:

Phase 3

Details

Lead Sponsor:

Wim Janssens

Collaborator:

Pro-Active Medical Pty Ltd

Treatments:

Azithromycin